Yuji Kurihara Selected Research

Yuji Kurihara Research Topics

Disease

8	Squamous Cell Carcinoma of Head and Neck 05/2023 - 01/2004
6	Diabetes Mellitus 02/2021 - 09/2019
5	Neoplasms (Cancer) 06/2022 - 06/2002
4	Drug-Related Side Effects and Adverse Reactions 02/2021 - 09/2016
3	Spinal Cord Injuries (Spinal Cord Injury) 12/2022 - 01/2017
3	Type 2 Diabetes Mellitus (MODY) 03/2020 - 09/2016
2	Ischemic Stroke 12/2022 - 01/2017
2	Infections 12/2013 - 04/2009
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2022
1	Rupture 06/2022
1	Glaucoma 01/2022
1	Blindness (Hysterical Blindness) 01/2022
1	Blepharitis 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Ocular Hypertension (Glaucoma, Suspect) 01/2022
1	Weight Loss (Weight Reduction) 07/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2020
1	Brain Ischemia (Cerebral Ischemia) 01/2020
1	Myxoma (Myxomas) 01/2019
1	Multiple Sclerosis 02/2018
1	Inflammation (Inflammations) 02/2018
1	Nervous System Diseases (Neurological Disorders) 02/2018
1	Neuroinflammatory Diseases 02/2018
1	Gliosis 01/2017
1	Migraine Disorders (Migraine) 07/2016
1	Seizures (Absence Seizure) 05/2016
1	Disease Progression 02/2015
1	Adenoid Cystic Carcinoma (Cylindroma) 12/2013
1	Carcinogenesis 09/2011
1	Neoplasm Metastasis (Metastasis) 10/2009
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2009
1	Inguinal Hernia (Direct Inguinal Hernia) 02/2008
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2004
1	Esophageal Neoplasms (Esophageal Cancer) 06/2004
1	Hemothorax 01/2004
1	Signet Ring Cell Carcinoma 06/2002
1	Carcinoma (Carcinomatosis) 06/2002

Drug/Important Bio-Agent (IBA)

8	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 02/2021 - 09/2016
4	SodiumIBA 07/2020 - 09/2016
4	Glucose (Dextrose)FDA LinkGeneric 07/2020 - 09/2016
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2009
2	Proteasome InhibitorsIBA 05/2023 - 03/2011
2	Nogo ReceptorsIBA 12/2022 - 01/2017
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2021 - 07/2020
2	Messenger RNA (mRNA)IBA 02/2018 - 12/2013
2	Biomarkers (Surrogate Marker)IBA 02/2018 - 02/2015
2	LigandsIBA 01/2017 - 03/2011
2	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2013 - 04/2009
2	IntegrinsIBA 10/2009 - 01/2009
2	Fluorouracil (Carac)FDA LinkGeneric 10/2009 - 11/2007
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2009 - 01/2004
2	N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA 01/2009 - 01/2004
2	Antisense OligonucleotidesIBA 01/2009 - 01/2004
2	Matrix Metalloproteinases (MMPs)IBA 01/2009 - 01/2009
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2009 - 01/2004
1	Imatinib Mesylate (Gleevec)FDA Link 06/2022
1	K-115IBA 01/2022
1	rho-Associated KinasesIBA 01/2022
1	Insulin (Novolin)FDA Link 03/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2020
1	Glucagon-Like Peptide-1 ReceptorIBA 11/2019
1	Nogo Receptor 1IBA 02/2018
1	LipopolysaccharidesIBA 02/2018
1	Sodium-Glucose Transport ProteinsIBA 11/2017
1	Chondroitin Sulfate ProteoglycansIBA 01/2017
1	Growth InhibitorsIBA 01/2017
1	SymportersIBA 09/2016
1	Valproic Acid (Depakote)FDA LinkGeneric 07/2016
1	TabletsIBA 07/2016
1	Carbapenems (Carbapenem Antibiotics)IBA 05/2016
1	Antineoplastic Agents (Antineoplastics)IBA 07/2012
1	benzo(c)phenanthridineIBA 09/2011
1	AlkaloidsIBA 09/2011
1	chelerythrineIBA 09/2011
1	sanguinarineIBA 09/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2011
1	matrigelIBA 01/2009
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2009
1	Phosphotransferases (Kinase)IBA 01/2009
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 01/2009
1	Indicators and Reagents (Reagents)IBA 01/2009
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2009
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2009
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2009
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2007
1	Cisplatin (Platino)FDA LinkGeneric 11/2007
1	Docetaxel (Taxotere)FDA Link 11/2007
1	Complementary DNA (cDNA)IBA 06/2004

Therapy/Procedure

2	Therapeutics 09/2019 - 02/2018
1	Operative Surgical Procedures 06/2022
1	Esophagectomy 06/2022
1	Neoadjuvant Therapy 06/2022
1	Oral Administration 06/2022
1	Curettage 01/2019
1	Length of Stay 02/2008
1	General Anesthesia 01/2004
1	Lasers (Laser) 06/2002